These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 12527167)
21. Human insulin plus sodium glycocholate in a nasal spray formulation: improved bioavailability and effectiveness in normal subjects. Pontiroli AE; Alberetto M; Pajetta E; Calderara A; Pozza G Diabete Metab; 1987; 13(4):441-3. PubMed ID: 3315765 [TBL] [Abstract][Full Text] [Related]
22. High absorbency and subchronic morphologic effects on the nasal epithelium of a nasal insulin powder dosage form with a soybean-derived sterylglucoside mixture in rabbits. Yamamoto T; Maitani Y; Ando T; Isowa K; Takayama K; Nagai T Biol Pharm Bull; 1998 Aug; 21(8):866-70. PubMed ID: 9743259 [TBL] [Abstract][Full Text] [Related]
23. Spray-dried powders of starch and crosslinked poly(acrylic acid) as carriers for nasal delivery of inactivated influenza vaccine. Coucke D; Schotsaert M; Libert C; Pringels E; Vervaet C; Foreman P; Saelens X; Remon JP Vaccine; 2009 Feb; 27(8):1279-86. PubMed ID: 19114075 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of the mucosal irritation potency of co-spray dried Amioca/poly(acrylic acid) and Amioca/Carbopol 974P mixtures. Adriaens E; Ameye D; Dhondt MM; Foreman P; Remon JP J Control Release; 2003 Mar; 88(3):393-9. PubMed ID: 12644365 [TBL] [Abstract][Full Text] [Related]
25. Role of surfactants in the bioavailability of intranasal insulin. Sanchez A; Ygartua P; Fos D Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():120-4. PubMed ID: 1820865 [TBL] [Abstract][Full Text] [Related]
26. Enhancing the oral bioavailability of the poorly soluble drug dicumarol with a bioadhesive polymer. Thanos CG; Liu Z; Goddard M; Reineke J; Bailey N; Cross M; Burrill R; Mathiowitz E J Pharm Sci; 2003 Aug; 92(8):1677-89. PubMed ID: 12884254 [TBL] [Abstract][Full Text] [Related]
27. Intranasal insulin. Clinical pharmacokinetics. Illum L; Davis SS Clin Pharmacokinet; 1992 Jul; 23(1):30-41. PubMed ID: 1617857 [TBL] [Abstract][Full Text] [Related]
29. Effect of insulin concentration on bioavailability during nasal spray administration. Valensi P; Zirinis P; Nicolas P; Perret G; Sandre-Banon D; Attali JR Pathol Biol (Paris); 1996 Apr; 44(4):235-40. PubMed ID: 8763584 [TBL] [Abstract][Full Text] [Related]
30. Nasal delivery of insulin using novel chitosan based formulations: a comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles. Dyer AM; Hinchcliffe M; Watts P; Castile J; Jabbal-Gill I; Nankervis R; Smith A; Illum L Pharm Res; 2002 Jul; 19(7):998-1008. PubMed ID: 12180553 [TBL] [Abstract][Full Text] [Related]
31. Effect of additives on insulin absorption from intratracheally administered dry powders in rats. Todo H; Okamoto H; Iida K; Danjo K Int J Pharm; 2001 Jun; 220(1-2):101-10. PubMed ID: 11376972 [TBL] [Abstract][Full Text] [Related]
32. Systemic delivery of insulin via the nasal route using a new microemulsion system: In vitro and in vivo studies. Sintov AC; Levy HV; Botner S J Control Release; 2010 Dec; 148(2):168-76. PubMed ID: 20709120 [TBL] [Abstract][Full Text] [Related]
33. Enhancing effect of cyclodextrins on nasal absorption of insulin and its duration in rabbits. Watanabe Y; Matsumoto Y; Kawamoto K; Yazawa S; Matsumoto M Chem Pharm Bull (Tokyo); 1992 Nov; 40(11):3100-4. PubMed ID: 1477928 [TBL] [Abstract][Full Text] [Related]
34. Influence of fillers in powder formulations containing N-acetyl-L-cysteine on nasal peptide absorption. Matsuyama T; Morita T; Horikiri Y; Yamahara H; Yoshino H J Control Release; 2007 Jul; 120(1-2):88-94. PubMed ID: 17512076 [TBL] [Abstract][Full Text] [Related]
35. One-month subchronic toxicity study of cell-penetrating peptides for insulin nasal delivery in rats. Khafagy el-S; Kamei N; Nielsen EJ; Nishio R; Takeda-Morishita M Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):736-43. PubMed ID: 24060698 [TBL] [Abstract][Full Text] [Related]
36. Nasal absorption and local tissue reaction of insulin nanocomplexes of trimethyl chitosan derivatives in rats. Jintapattanakit A; Peungvicha P; Sailasuta A; Kissel T; Junyaprasert VB J Pharm Pharmacol; 2010 May; 62(5):583-91. PubMed ID: 20609059 [TBL] [Abstract][Full Text] [Related]
37. Insulin gel as an alternate to parenteral insulin: formulation, preclinical, and clinical studies. D'Souza R; Mutalik S; Venkatesh M; Vidyasagar S; Udupa N AAPS PharmSciTech; 2005 Sep; 6(2):E184-9. PubMed ID: 16353976 [TBL] [Abstract][Full Text] [Related]
38. Effective insulin delivery using starch nanoparticles as a potential trans-nasal mucoadhesive carrier. Jain AK; Khar RK; Ahmed FJ; Diwan PV Eur J Pharm Biopharm; 2008 Jun; 69(2):426-35. PubMed ID: 18295464 [TBL] [Abstract][Full Text] [Related]
39. Comparative pharmacoscintigraphic and pharmacokinetic evaluation of two new formulations of inhaled insulin in type 1 diabetic patients. Depreter F; Burniat A; Blocklet D; Lacroix S; Cnop M; Fery F; Aelst NV; Pilcer G; Deleers M; Goldman S; Amighi K Eur J Pharm Biopharm; 2012 Jan; 80(1):4-13. PubMed ID: 21983605 [TBL] [Abstract][Full Text] [Related]
40. Bioadhesive starch microspheres and absorption enhancing agents act synergistically to enhance the nasal absorption of polypeptides. Illum L; Fisher AN; Jabbal-Gill I; Davis SS Int J Pharm; 2001 Jul; 222(1):109-19. PubMed ID: 11404037 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]